334
views
0
recommends
+1 Recommend
1 collections
    4
    shares
       
      • Record: found
      • Abstract: found
      • Poster: found
      Is Open Access

      Therapeutic Antibodies and Cancer Vaccines

      research-article

        1 ,

      ScienceOpen Posters

      ScienceOpen

      Cancer, Therapeutic Vaccines

      Bookmark

            Abstract

            Antibodies are proteins synthesized in blood against specific antigens. Antigen binding causes activation, proliferation and differentiation of the B cells. After activation, B cells becomes plasma cells and secrete antibodies. Therapeutic antibodies are monoclonal antibodies and use as passive immunotherapy for the treatment of cancer. It is well established option in clinical oncology. Anticancer vaccines are less advanced because of some exception of successfully applied prophylactic vaccines against oncogenic virus infections. The formation of therapeutic vaccine is still a great challenge due to the self nature of tumor antigens. Therapeutic antibodies as vaccines against cancer are produced in healthy cells by using cancer antigens and use for the patient to treat existing cancer by strengthening the natural defense of the body against cancer.

            Content

            Author and article information

            Journal
            ScienceOpen Posters
            ScienceOpen
            15 November 2019
            Affiliations
            [1 ] Department of Biotechnology, Veer Narmad South Gujarat University, Surat 395007, Gujarat, India.
            Article
            10.14293/S2199-1006.1.SOR-.PPEM7XD.v1
            78c0c853-b279-4f97-b9ac-dbdcb3dd07bb

            This work has been published open access under Creative Commons Attribution License CC BY 4.0 , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com .

            Medicine, Life sciences

            Cancer, Therapeutic Vaccines

            Comments

            Comment on this article